These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22026398)

  • 41. Issues in cyclosporine drug substitution: implications for patient management.
    Bartucci MR
    J Transpl Coord; 1999 Sep; 9(3):137-42; quiz 143-4. PubMed ID: 10703396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developmental pharmacogenetics of immunosuppressants in pediatric organ transplantation.
    Zhao W; Fakhoury M; Jacqz-Aigrain E
    Ther Drug Monit; 2010 Dec; 32(6):688-99. PubMed ID: 21068645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results.
    Abdallah TB; Ounissi M; Cherif M; Helal I; Karoui C; Mhibik S; Bacha MM; Abderrahim E; Kheder A
    Exp Clin Transplant; 2010 Dec; 8(4):292-6. PubMed ID: 21143094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.
    Tsai SF; Cheng CY; Shu KH; Wu MJ
    Transplant Proc; 2012 Jan; 44(1):190-2. PubMed ID: 22310612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Top 10 Things Primary Care Physicians Should Know About Maintenance Immunosuppression for Transplant Recipients.
    Lien YH
    Am J Med; 2016 Jun; 129(6):568-72. PubMed ID: 26714210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients.
    Andrews LM; Riva N; de Winter BC; Hesselink DA; de Wildt SN; Cransberg K; van Gelder T
    Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):921-36. PubMed ID: 25865963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generic Medicinal Products in Immunosuppressive Therapy-Should It be a Challenge for Therapeutic Drug Monitoring?
    Kocur A; Kunicki PK; Pawiński T
    Ther Drug Monit; 2023 Apr; 45(2):173-190. PubMed ID: 36920502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tacrolimus in transplant rejection.
    Rath T
    Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Important considerations for drugs, nutritional, and herbal supplements in pediatric solid organ transplant recipients.
    Pilch NA; Sell ML; McGhee W; Venkataramanan R
    Pediatr Transplant; 2021 Feb; 25(1):e13881. PubMed ID: 33142023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis.
    Molnar AO; Fergusson D; Tsampalieros AK; Bennett A; Fergusson N; Ramsay T; Knoll GA
    BMJ; 2015 Jun; 350():h3163. PubMed ID: 26101226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug monitoring data.
    Trkulja V; Lalić Z; Nađ-Škegro S; Lebo A; Granić P; Lovrić M; Pasini J; Božina N
    Ther Drug Monit; 2014 Aug; 36(4):456-64. PubMed ID: 24518562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.
    Taylor AL; Watson CJ; Bradley JA
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):23-46. PubMed ID: 16039869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Switching immunosuppressive drugs in kidney transplant recipients: "show me the evidence".
    Ansari MJ; Sayegh MH
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):149-52. PubMed ID: 16903619
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pilot study on the efficacy and safety of generic mycophenolate mofetil (Mycept) compared with Cellcept among incident low-risk primary kidney transplant recipients.
    Danguilan RA; Lamban AB; Luna CA; Bacinillo M; Momongan MI
    Transplant Proc; 2014; 46(2):415-7. PubMed ID: 24655977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
    Hunt SA
    Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
    Tönshoff B; David-Neto E; Ettenger R; Filler G; van Gelder T; Goebel J; Kuypers DR; Tsai E; Vinks AA; Weber LT; Zimmerhackl LB
    Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Consensus statement of the Croatian Society for Nephrology, Dialysis and Transplantation regarding the use of generic immunosuppressive drugs].
    Bašić-Jukić N; Rački S; Knotek M; Bubić-Filipi L; Bubić I; Zibar L; Kes P;
    Acta Med Croatica; 2014 Apr; 68(2):211-4. PubMed ID: 26012162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.